Tang R - Search Results

1

A novel form of docetaxel polymeric micelles demonstrates anti-tumor and ascites-inhibitory activities in animal models as monotherapy or in combination with anti-angiogenic agents.

Guo L, Qin X, Xue L, Yang JY, Zhang Y, Zhu S, Ye G, Tang R, Yang W. Guo L, et al. Among authors: tang r. Front Pharmacol. 2022 Aug 24;13:964076. doi: 10.3389/fphar.2022.964076. eCollection 2022. Front Pharmacol. 2022. PMID: 36091776 Free PMC article.

2

Antiangiogenic antibody BD0801 combined with immune checkpoint inhibitors achieves synergistic antitumor activity and affects the tumor microenvironment.

Xue L, Gao X, Zhang H, Tang J, Wang Q, Li F, Li X, Yu X, Lu Z, Huang Y, Tang R, Yang W. Xue L, et al. Among authors: tang r, tang j. BMC Cancer. 2021 Oct 22;21(1):1134. doi: 10.1186/s12885-021-08859-5. BMC Cancer. 2021. PMID: 34686154 Free PMC article.

3

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors.

Gu P, Xue L, Zhao C, Li W, Jiang Z, Liu A, Li T, Liu L, Decker M, Cheng X, Yang W, Tang R. Gu P, et al. Among authors: tang r. Front Oncol. 2022 May 13;12:885186. doi: 10.3389/fonc.2022.885186. eCollection 2022. Front Oncol. 2022. PMID: 35646698 Free PMC article.

4

Efficacy and safety of Y-2 sublingual tablet for patients with acute ischaemic stroke: protocol of a phase III randomised double-blind placebo-controlled multicentre trial.

Fu Y, Tang R, Chen R, Wang A, Ren J, Zhu S, Feng X, Fan D. Fu Y, et al. Among authors: tang r. Stroke Vasc Neurol. 2024 Feb 27;9(1):90-95. doi: 10.1136/svn-2022-002014. Stroke Vasc Neurol. 2024. PMID: 37308251 Free PMC article.

5

SCR-6852, an oral and highly brain-penetrating estrogen receptor degrader (SERD), effectively shrinks tumors both in intracranial and subcutaneous ER + breast cancer models.

Zhou F, Yang G, Xue L, Liu Y, Guo Y, Zhu J, Yuan L, Gu P, Tang F, Shan J, Tang R. Zhou F, et al. Among authors: tang f, tang r. Breast Cancer Res. 2023 Aug 14;25(1):96. doi: 10.1186/s13058-023-01695-4. Breast Cancer Res. 2023. PMID: 37580832 Free PMC article.

6

Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke: The TASTE-SL Randomized Clinical Trial.

Fu Y, Wang A, Tang R, Li S, Tian X, Xia X, Ren J, Yang S, Chen R, Zhu S, Feng X, Yao J, Wei Y, Dong X, Ling Y, Yi F, Deng Q, Guo C, Sui Y, Han S, Wen G, Li C, Dong A, Sun X, Wang Z, Shi X, Liu B, Fan D. Fu Y, et al. Among authors: tang r. JAMA Neurol. 2024 Feb 19;81(4):319-26. doi: 10.1001/jamaneurol.2023.5716. Online ahead of print. JAMA Neurol. 2024. PMID: 38372981 Free PMC article.

7

Engineering cytokines for cancer immunotherapy: a systematic review.

Fu Y, Tang R, Zhao X. Fu Y, et al. Among authors: tang r. Front Immunol. 2023 Jul 6;14:1218082. doi: 10.3389/fimmu.2023.1218082. eCollection 2023. Front Immunol. 2023. PMID: 37483629 Free PMC article. Review.

8

Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.

Zhang W, Zhao S, Luo Y, Zhang Y, Feng Y, Tang F, Zhou X, Peng S, Fan Y, Xie S, Li H, Lai Q, Fu L, Luo Y, Pei S, Chen Z, Lu T, Tang R, Chen Y, Jiao Y. Zhang W, et al. Among authors: tang f, tang r. J Med Chem. 2024 Jan 11;67(1):322-348. doi: 10.1021/acs.jmedchem.3c01417. Epub 2023 Dec 21. J Med Chem. 2024. PMID: 38128906

9

Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir.

Jiang X, Su H, Shang W, Zhou F, Zhang Y, Zhao W, Zhang Q, Xie H, Jiang L, Nie T, Yang F, Xiong M, Huang X, Li M, Chen P, Peng S, Xiao G, Jiang H, Tang R, Zhang L, Shen J, Xu Y. Jiang X, et al. Among authors: tang r. Nat Commun. 2023 Oct 13;14(1):6463. doi: 10.1038/s41467-023-42102-y. Nat Commun. 2023. PMID: 37833261 Free PMC article.

10

A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects.

Yang XM, Yang Y, Yao BF, Ye PP, Xu Y, Peng SP, Yang YM, Shu P, Li PJ, Li S, Hu HL, Li Q, Song LL, Chen KG, Zhou HY, Zhang YH, Zhao FR, Tang BH, Zhang W, Zhang XF, Fu SM, Hao GX, Zheng Y, Shen JS, Xu YC, Jiang XR, Zhang LK, Tang RH, Zhao W. Yang XM, et al. Eur J Pharm Sci. 2023 Dec 1;191:106598. doi: 10.1016/j.ejps.2023.106598. Epub 2023 Sep 30. Eur J Pharm Sci. 2023. PMID: 37783378 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,924 results

Search Page